#Japan #Tokyo #TOYP #Eisuke Shimizu #OUI

Eisuke Shimizu Acknowledged as a Top Ten Global Leader in Medicine

Eisuke Shimizu, the CEO of OUI Inc. and a skilled ophthalmologist, has earned a prestigious position as one of the ten outstanding young people globally, recognized by the Junior Chamber International (JCI). The announcement was made by the Japanese Junior Chamber (日本JC), which has been an instrumental organization in recognizing remarkable achievements among youth since 1987. Shimizu was awarded the Grand Prize in the 2024 JCI Japan TOYP and subsequently selected from a competitive pool of over 120 candidates spanning 30 countries for the global recognition.

Understanding the JCI TOYP

The TOYP (The Outstanding Young Persons) initiative serves as a tribute to remarkable young individuals who have made significant positive impacts on society worldwide. It was originally initiated in the United States in 1938 as 'TOYM' (Ten Outstanding Young Men) and has evolved under JCI since 1983. The initiative aims to identify and celebrate outstanding young people in various fields and amplify their contributions, ultimately fostering a cycle of positive change in communities.

Previous laureates include notable figures such as John F. Kennedy, Bill Clinton, and Elvis Presley, making it a prestigious accolade that Shimizu now proudly joins.

Achievements of Eisuke Shimizu

In 2016, after graduating from Keio University School of Medicine, Shimizu founded OUI Inc. with the mission to reduce global blindness by 50%. His company developed a groundbreaking medical device known as the 'Smart Eye Camera,' which allows for eye examinations to be conducted easily via smartphones. This innovation has enabled accessibility to precise eye care, regardless of the location.

To date, his efforts have resulted in over 150,000 eye consultations across more than 60 developing countries, including regions in Africa, Southeast Asia, and South America. This initiative has significantly contributed to mitigating the immense socio-economic losses attributed to ocular disabilities, estimated to be around 720 trillion yen.

Shimizu is also passionate about broadening partnerships worldwide and is committed to eye health advocacy, educating ophthalmologists in developed nations while providing treatment options in underserved regions.

A Glimpse into the Future

As Shimizu joins the ranks of legendary achievers in the TOYP program, the final results of the global competition will be publicly unveiled on November 8, 2025, during the JCI World Conference, taking place in Tunisia. This event promises to spotlight the incredible contributions of young leaders such as Shimizu, further inspiring future generations to make impactful changes in their respective fields.

For those interested in following Shimizu’s remarkable journey, a promotional video is available through the link provided, showcasing his dedication and the significant impact he has made in the field of eye care: Eisuke Shimizu Introduction Video.

Shimizu's background includes specialized studies in dry eye and ocular allergies, completing numerous clinical and fundamental research projects related to severe dry eye associated with autoimmune diseases. With his innovative spirit and commitment to improving global health, Eisuke Shimizu has successfully positioned himself as an agent of change in the medical field and beyond.